
Smarter Decisions. AI Optimized Trials.
PhaseV is a Boston-based technology company that uses causal machine learning and generative AI, augmented by a large patient-level data lake, to help biopharma sponsors and CROs make faster and more accurate clinical development decisions. Its platform supports adaptive trial design, patient stratification, site selection, and portfolio optimization.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create a free account to see which investors have funded this company.
Create Free Account